Docusign (NASDAQ:DOCU) Director Sells $28,897.96 in Stock

Key Points

• Docusign Director Teresa Briggs sold 364 shares of the company's stock for $28,897.96, leading to a 3.82% decrease in her ownership.
• The company reported an EPS of $0.92 for the last quarter, exceeding analysts' expectations, with revenue totaling $800.64 million, a year-over-year increase of 8.8%.
• Docusign's Board initiated a $1.00 billion share buyback plan, which indicates belief from management that the shares are undervalued.

Docusign Inc. (NASDAQ:DOCU - Get Free Report) Director Teresa Briggs sold 364 shares of the company's stock in a transaction on Thursday, September 11th. The shares were sold at an average price of $79.39, for a total transaction of $28,897.96. Following the sale, the director owned 9,170 shares of the company's stock, valued at $728,006.30. This represents a 3.82% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Teresa Briggs also recently made the following trade(s):

• On Monday, June 16th, Teresa Briggs sold 534 shares of Docusign stock. The shares were sold at an average price of $74.37, for a total transaction of $39,713.58.

Docusign Stock Performance

NASDAQ:DOCU traded up $1.42 during midday trading on Thursday, reaching $80.24. 3,768,196 shares of the stock traded hands, compared to its average volume of 2,682,463. The company has a fifty day moving average of $75.69 and a 200 day moving average of $79.29. Docusign Inc. has a 12 month low of $55.14 and a 12 month high of $107.86. The stock has a market capitalization of $16.14 billion, a P/E ratio of 60.33, a PEG ratio of 4.18 and a beta of 1.02.

Docusign (NASDAQ:DOCU - Get Free Report) last posted its quarterly earnings results on Thursday, September 4th. The company reported $0.92 EPS for the quarter, beating analysts' consensus estimates of $0.84 by $0.08. Docusign had a net margin of 9.08% and a return on equity of 14.01%. The company had revenue of $800.64 million during the quarter, compared to analyst estimates of $780.35 million. During the same period in the prior year, the business posted $0.97 EPS. The firm's revenue was up 8.8% compared to the same quarter last year. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. On average, analysts predict that Docusign Inc. will post 1.17 EPS for the current fiscal year.

Docusign declared that its Board of Directors has initiated a share buyback plan on Thursday, June 5th that authorizes the company to buyback $1.00 billion in outstanding shares. This buyback authorization authorizes the company to purchase up to 6.6% of its shares through open market purchases. Shares buyback plans are generally an indication that the company's management believes its shares are undervalued.

Wall Street Analysts Forecast Growth

DOCU has been the topic of a number of research analyst reports. JPMorgan Chase & Co. boosted their price objective on shares of Docusign from $77.00 to $80.00 and gave the company a "neutral" rating in a research report on Friday, September 5th. Royal Bank Of Canada boosted their price objective on shares of Docusign from $90.00 to $95.00 and gave the company a "sector perform" rating in a research report on Friday, September 5th. Zacks Research raised shares of Docusign from a "hold" rating to a "strong-buy" rating in a research report on Tuesday. Piper Sandler boosted their price objective on shares of Docusign from $85.00 to $90.00 and gave the company a "neutral" rating in a research report on Friday, September 5th. Finally, Evercore ISI boosted their price objective on shares of Docusign from $90.00 to $92.00 and gave the company an "in-line" rating in a research report on Friday, September 5th. One equities research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and fourteen have given a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $94.14.

Institutional Trading of Docusign

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Norges Bank bought a new position in Docusign in the 2nd quarter worth about $140,987,000. Wellington Management Group LLP boosted its stake in Docusign by 372.5% in the 1st quarter. Wellington Management Group LLP now owns 1,826,949 shares of the company's stock worth $148,714,000 after purchasing an additional 1,440,269 shares in the last quarter. Duquesne Family Office LLC bought a new position in Docusign in the 1st quarter worth about $87,477,000. Pacer Advisors Inc. boosted its stake in Docusign by 809.6% in the 1st quarter. Pacer Advisors Inc. now owns 1,167,290 shares of the company's stock worth $95,017,000 after purchasing an additional 1,038,962 shares in the last quarter. Finally, Third Point LLC bought a new position in Docusign in the 2nd quarter worth about $48,681,000. 77.64% of the stock is owned by hedge funds and other institutional investors.

Docusign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.